Glycogen Storage Disease Type 13 Overview
Save information for later
Sign Up
Learn About Glycogen Storage Disease Type 13
What is the definition of Glycogen Storage Disease Type 13?
Glycogen storage disease type 13 (GSD13), also known as β-enolase deficiency, is an inherited disease of the muscles. The muscles of an affected individual are not able to produce enough energy to function properly, causing muscle weakness and pain. GSD13 is caused by changes in the ENO3 gene and is inherited in an autosomal recessive pattern.
What are the alternative names for Glycogen Storage Disease Type 13?
- Glycogen storage disease type 13
- Enolase 3 deficiency
- Enolase-beta deficiency
- GSD13
- Glycogen storage disease 13
Who are the top Glycogen Storage Disease Type 13 Local Doctors?
No local doctors have been found near Sheboygan, The United States. Expand the search radius or change your location here.
What are the latest Glycogen Storage Disease Type 13 Clinical Trials?
Who are the sources who wrote this article ?
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
What are the Latest Advances for Glycogen Storage Disease Type 13?
SHP2 regulates the HIF-1 signaling pathway in the decidual human endometrial stromal cells.
Journal: Biology of reproduction
Published: September 13, 2024
Acupoint thread-embedding for children with tic disorders of spleen deficiency and liver hyperactivity and its effect on serum level of NSE.
Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion
Published: November 21, 2023
Tired of the same old research?
Check Latest Advances